Aurinia Pharmaceuticals Inc. AUPH
NASDAQ · United States · Health Technology
$16.02-0.18 (-1.08%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 0.28 | 0.24 | +16.7% | $83.22M | +3.4% | +4.3%$15.19→$15.85 |
| Q1 2026 | 2026-05-07 | 0.25 | 0.20 | +25.0% | — | — | -6.2%$16.25→$15.23 |
| Q4 2025 | 2026-02-26 | 1.53 | 0.22 | +595.5% | — | — | -1.8%$14.43→$14.17 |
| Q3 2025 | 2025-11-04 | 0.23 | 0.16 | +43.8% | — | — | +9.7%$13.17→$14.45 |
| Q2 2025 | 2025-07-31 | 0.16 | 0.15 | +6.7% | — | — | — |
| Q1 2025 | 2025-05-12 | 0.16 | 0.10 | +60.0% | — | — | — |
| Q4 2024 | 2025-02-27 | 0.01 | -0.02 | +150.0% | — | — | — |
| Q2 2024 | 2024-08-01 | 0.01 | 0.01 | 0.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.